When combined with Semaglutide in the CagriSema protocol, weight loss exceeded 22%, showing Cagrilintide has strong synergistic potential with the GLP-1 pathway
Discontinue use and consult a clinician if unexplained symptoms arise
Today, Ipamorelin remains one of the most widely studied GHRP-family peptides and continues to serve as an important research tool for investigating growth hormone physiology, endocrine regulation, and metabolic adaptation
10.1038/nm.2536 21 D'ArcyP.WangX.LinderS
Who Treats This Condition These providers specialize in this area and review every patient's case personally
The most common side effects are mild injection site reactions (redness, tenderness), temporary fatigue, and occasional headaches